Shock is a life-threatening state of circulatory failure in which tissue oxygen delivery is insufficient to meet metabolic demand. It is one of the leading causes of ICU admission and a top NCLEX focus because it requires rapid identification and intervention. Left untreated, shock progresses through compensated, decompensated, and irreversible stages, leading to multi-organ failure and death. Nursing students who understand shock pathophysiology, recognize early warning signs, and know which interventions target each type will respond faster, communicate more effectively with physicians, and perform better on NCLEX and in clinical rotations. This reference covers all four shock categories — hypovolemic, cardiogenic, distributive, and obstructive — with hemodynamic parameters, nursing interventions, and a medication reference table.
Use this page alongside the sepsis nursing guide, ICU critical care reference, trauma and emergency nursing reference, and DIC nursing reference.
Fast-scan: all four shock types at a glance
| Type | Core mechanism | CO | SVR | PCWP | Classic presentation |
|---|---|---|---|---|---|
| Hypovolemic | Loss of intravascular volume | ↓ | ↑ | ↓ | Hemorrhage, burns, vomiting, diarrhea; tachycardia, flat neck veins, cool/clammy skin |
| Cardiogenic | Pump failure | ↓ | ↑ | ↑ | MI, HF, arrhythmia; tachycardia, pulmonary edema, JVD, S3 gallop |
| Distributive | Massive vasodilation → maldistribution | ↑ (early) | ↓ | ↓ | Sepsis, anaphylaxis, neurogenic; warm/flushed skin (early), hypotension, wide pulse pressure |
| Obstructive | Mechanical obstruction to flow | ↓ | ↑ | Variable | PE, tension pneumothorax, cardiac tamponade; obstructive JVD, hypotension, dyspnea |
CO = cardiac output; SVR = systemic vascular resistance; PCWP = pulmonary capillary wedge pressure (reflects left-heart filling pressure).
Hypovolemic shock
Causes
Hypovolemic shock results from absolute loss of intravascular volume. The two major sub-categories are hemorrhagic (trauma, GI bleed, ruptured ectopic pregnancy, post-surgical) and non-hemorrhagic (severe vomiting, diarrhea, burns, diabetic ketoacidosis with osmotic diuresis, third-spacing in pancreatitis or bowel obstruction). See the GI bleed nursing reference and burns nursing reference for condition-specific management.
Pathophysiology
When circulating volume falls, venous return drops, cardiac output falls, and the body compensates by activating the sympathetic nervous system and the renin-angiotensin-aldosterone axis. Catecholamine release causes tachycardia, arterial vasoconstriction (↑ SVR), and selective tissue hypoperfusion — the body shunts blood away from the gut, skin, and kidneys to protect the brain and heart. Preload (PCWP) falls because the tank is empty. Without intervention, compensatory vasoconstriction fails and blood pressure plummets.
Assessment findings
- Tachycardia (often the earliest sign), hypotension (late)
- Pale, cool, diaphoretic skin
- Flat or collapsed neck veins (JVD absent)
- Decreased urine output (<0.5 mL/kg/hr)
- Altered mental status (restlessness → confusion → obtundation)
- Narrowing pulse pressure
- Increased hematocrit in early hemorrhage (hemodilution reverses it later)
Class I–IV hemorrhage staging: Class I (<15% blood loss) presents with minimal signs; Class IV (>40%) presents with severe hypotension, marked tachycardia (>140 bpm), and minimal urine output — immediate surgical or procedural intervention required.
Nursing interventions
- Position: Modified Trendelenburg (legs elevated 15°) to augment venous return — avoid full Trendelenburg, which worsens respiratory mechanics without improving perfusion.
- Two large-bore IVs (16-gauge or larger) or IO access; draw labs on insertion (CBC, BMP, coagulation, type and screen).
- Fluid resuscitation: isotonic crystalloids (normal saline or lactated Ringer’s); in hemorrhagic shock, transition to 1:1:1 packed red blood cells, fresh frozen plasma, and platelets (damage control resuscitation).
- Oxygen via non-rebreather mask at 15 L/min; prepare for intubation if deteriorating.
- Continuous hemodynamic monitoring: arterial line for beat-to-beat BP, urinary catheter for output, reassess every 15–30 minutes.
- Identify and treat the source: pressure dressings, tourniquet, urgent endoscopy, surgical consult.
- Keep patient warm — hypothermia impairs coagulation and worsens acidosis (lethal triad: hypothermia, acidosis, coagulopathy).
Cardiogenic shock
Causes
Cardiogenic shock occurs when the heart fails as a pump. The most common cause is ST-elevation myocardial infarction (STEMI) — particularly anterior MI involving the left anterior descending artery — which accounts for approximately 40–80% of cases. Other causes include decompensated heart failure, severe valvular disease (acute mitral regurgitation, aortic stenosis), myocarditis, massive pulmonary embolism causing right heart failure, and life-threatening arrhythmias. Review the MI/ACS nursing guide and heart failure nursing guide for related clinical context.
Pathophysiology
Pump failure reduces stroke volume and cardiac output. The body compensates by increasing heart rate (sympathetic activation) and vasoconstricting (↑ SVR), which increases afterload on the already-failing heart and worsens the cycle. The left ventricle cannot empty effectively, so back-pressure builds — PCWP rises and pulmonary edema develops. Despite a full or over-filled circuit (high PCWP), the forward flow to tissues is inadequate.
Assessment findings
- Tachycardia with hypotension (SBP <90 mmHg or MAP <65 mmHg)
- Jugular venous distension (JVD) — elevated filling pressures
- Bilateral crackles / pulmonary edema (back-pressure into the lungs)
- S3 gallop, displaced point of maximal impulse
- Cool, mottled extremities (low output vasoconstriction)
- Elevated BNP, elevated troponin (if MI-related)
- Decreased urine output, rising creatinine (renal hypoperfusion)
- Elevated serum lactate (>2 mmol/L indicates inadequate tissue perfusion)
Nursing interventions
- Elevate head of bed 30–45° to ease respiratory work and reduce preload (reduces pulmonary edema — opposite position from hypovolemic shock).
- Supplemental oxygen; prepare for non-invasive positive pressure ventilation (CPAP/BiPAP) or intubation.
- Vasoactive support: norepinephrine for hemodynamic stabilization; dobutamine for inotropic support to increase contractility. Vasopressors and inotropes are titrated simultaneously in many cardiogenic shock protocols.
- Avoid aggressive fluids — the tank is full; additional volume worsens pulmonary edema.
- Continuous cardiac monitoring: 12-lead EKG, serial troponins, bedside echocardiography.
- Prepare for emergent revascularization (PCI) if STEMI-related — time to reperfusion is the primary determinant of outcome.
- Mechanical circulatory support: intra-aortic balloon pump (IABP), Impella, or ECMO may be required for refractory cardiogenic shock.
- Monitor potassium closely — hypokalemia in the setting of diuretic use increases arrhythmia risk. See the electrolyte imbalances reference.
Distributive shock
Distributive shock is characterized by profound peripheral vasodilation and maldistribution of blood flow. The total body volume is unchanged, but vascular tone is lost — vessels dilate so much that even a normal cardiac output cannot maintain adequate perfusion pressure. Early distributive shock presents with warm, flushed skin and a bounding pulse (high CO, low SVR), distinguishing it from the other shock types. There are three major subtypes.
Septic shock
Septic shock is the most common form of distributive shock and a leading cause of ICU death. It occurs when infection triggers systemic inflammation (SIRS), progressing to organ dysfunction (sepsis) and refractory hypotension requiring vasopressors despite adequate fluid resuscitation (septic shock — Sepsis-3 definition). Bacterial infections are most common, but fungal, viral, and parasitic etiologies occur. The inflammatory cascade releases cytokines (TNF-α, IL-1, IL-6) that cause endothelial damage, capillary leak, and profound vasodilation.
Key interventions follow the Surviving Sepsis Campaign Hour-1 bundle: obtain blood cultures (before antibiotics if possible), administer broad-spectrum antibiotics within 1 hour, begin 30 mL/kg IV crystalloid resuscitation for hypotension or lactate ≥4 mmol/L, initiate vasopressors (norepinephrine first-line) targeting MAP ≥65 mmHg, remeasure lactate if initial lactate ≥2 mmol/L. See the sepsis nursing reference for full protocols.
Anaphylactic shock
Anaphylaxis is a severe, life-threatening hypersensitivity reaction driven by IgE-mediated (or non-IgE-mediated) mast cell degranulation. Triggers include foods (peanuts, shellfish), drugs (beta-lactam antibiotics, NSAIDs, contrast media), insect stings, and latex. Histamine and other mediators cause massive vasodilation, increased capillary permeability, bronchospasm, and laryngeal edema.
First-line treatment is epinephrine 0.3–0.5 mg IM into the anterolateral thigh (not IV unless peri-arrest). Epinephrine reverses bronchospasm (β2), vasoconstricts (α1), and increases cardiac output (β1). Secondary interventions include IV fluids (1–2 L NS rapidly), diphenhydramine, corticosteroids, and inhaled bronchodilators for persistent bronchospasm. Position supine with legs elevated if no respiratory distress. Keep the patient monitored for at least 4–6 hours given the risk of biphasic reaction.
Neurogenic shock
Neurogenic shock results from spinal cord injury at T6 or above, which disrupts sympathetic outflow. Without sympathetic tone, vessels dilate unchecked and the heart loses its sympathetic rate acceleration. The clinical triad is hypotension, bradycardia, and warm/dry skin (no compensatory tachycardia or diaphoresis). Management prioritizes spinal immobilization, fluid resuscitation, and vasopressors (norepinephrine or phenylephrine) to restore vascular tone; atropine or transcutaneous pacing may be required for bradycardia. See the spinal cord injury nursing guide for additional context.
Obstructive shock
Obstructive shock occurs when a physical obstruction prevents adequate cardiac output despite a functioning heart and adequate volume. The common thread is mechanical impairment of ventricular filling or outflow. The three most clinically important causes are pulmonary embolism, tension pneumothorax, and cardiac tamponade.
Pulmonary embolism
Massive PE obstructs the right ventricular outflow tract, causing acute right heart failure, impaired left ventricular filling, and a precipitous fall in cardiac output. Signs include sudden-onset dyspnea, pleuritic chest pain, tachycardia, hypoxia, and hypotension. The ECG may show S1Q3T3 pattern or new right bundle branch block. Treatment: anticoagulation (unfractionated heparin), systemic thrombolytics for massive PE with hemodynamic collapse, or catheter-directed thrombolysis/embolectomy for submassive or refractory cases. See the DVT/PE nursing guide for full management.
Tension pneumothorax
Air accumulates under pressure in the pleural space, compressing the ipsilateral lung and shifting mediastinal structures (tracheal deviation away from the affected side). Compression of the superior and inferior vena cava impairs venous return; cardiac output collapses. Signs: absent breath sounds on affected side, tracheal deviation, JVD, hypotension, severe respiratory distress. Treatment is immediate needle decompression (second intercostal space, midclavicular line) followed by chest tube insertion — do not wait for chest X-ray when clinical presentation is clear. See the pneumothorax nursing guide for procedural details.
Cardiac tamponade
Fluid accumulation in the pericardial sac compresses the heart, preventing diastolic filling. Beck’s triad identifies the classic presentation: hypotension, muffled heart sounds, and JVD. Pulsus paradoxus (>10 mmHg drop in SBP with inspiration) is highly specific. Causes include trauma, malignancy, uremia, post-cardiac surgery, and inflammatory pericarditis. Definitive treatment is pericardiocentesis or surgical drainage. Avoid diuretics and vasodilators, which reduce preload and worsen tamponade physiology.
NCLEX-style shock assessment: hemodynamic parameters and stages
Hemodynamic parameters
| Parameter | Normal range | Hypovolemic | Cardiogenic | Distributive | Obstructive |
|---|---|---|---|---|---|
| MAP (mmHg) | 70–100 | ↓ | ↓ | ↓ | ↓ |
| HR (bpm) | 60–100 | ↑↑ | ↑↑ | ↑↑ (except neurogenic: ↓) | ↑↑ |
| CO (L/min) | 4–8 | ↓ | ↓↓ | ↑ (early) / ↓ (late) | ↓ |
| SVR (dynes·s/cm⁵) | 800–1200 | ↑ | ↑↑ | ↓↓ | ↑ |
| PCWP (mmHg) | 6–12 | ↓ | ↑↑ | ↓ | ↑ (tamponade/PE) |
| CVP (mmHg) | 2–8 | ↓ | ↑ | ↓ | ↑ |
| Urine output | >0.5 mL/kg/hr | ↓ | ↓ | ↓ | ↓ |
| Serum lactate | <2 mmol/L | ↑ | ↑ | ↑↑ | ↑ |
MAP target in shock management: ≥65 mmHg is the standard vasopressor target per Surviving Sepsis Campaign guidelines and general critical care practice. Higher MAP targets (80–85 mmHg) have not been shown to improve survival and may increase arrhythmia burden in some populations (SEPSISPAM trial).
Stages of shock
All shock types progress through three stages if untreated:
Stage 1 – Compensated (early): BP maintained by compensatory mechanisms (tachycardia, vasoconstriction, ADH/RAAS activation). Subtle signs: anxiety, restlessness, slight tachycardia, decreased urine output, skin changes (cool/pale in hypovolemic/cardiogenic; warm/flushed in distributive early phase).
Stage 2 – Decompensated (progressive): Compensation fails. Hypotension becomes manifest. Metabolic acidosis develops (lactate rises from anaerobic metabolism). Confusion, marked tachycardia, oliguria (<30 mL/hr), diaphoresis.
Stage 3 – Irreversible (refractory): Cellular death, multi-organ failure (MOF). Renal, hepatic, and pulmonary systems fail. Coagulopathy (DIC) may develop. Even with maximal intervention, survival is unlikely. See the DIC nursing reference for coagulopathy management.
Nursing interventions: universal priorities in shock
Regardless of shock type, the following framework applies:
-
Airway and oxygenation: Administer high-flow oxygen; position the airway; prepare for intubation in decompensating patients. Target SpO2 ≥94%. See the ABG interpretation guide for respiratory acid-base assessment.
-
Vascular access and labs: Two large-bore IVs or central venous access. Draw: CBC, BMP, lactate, coagulation studies, blood cultures (if infection suspected), type and screen. Consider arterial line for continuous BP monitoring.
-
Volume resuscitation (type-specific):
- Hypovolemic: aggressive crystalloid + blood products
- Distributive (septic): 30 mL/kg crystalloid bolus within 3 hours
- Cardiogenic: cautious or no fluid (avoid worsening pulmonary edema)
- Obstructive: targeted to cause (small fluid challenge while awaiting definitive treatment)
-
Vasopressors: Initiate when MAP <65 mmHg despite fluid resuscitation. See medication table below.
-
Positioning: Legs elevated for hypovolemic and distributive; HOB elevated for cardiogenic. Patient positioning decisions directly affect hemodynamic outcomes.
-
Monitoring and reassessment: Continuous cardiac monitoring, urinary catheter for hourly output, repeat lactate in 2 hours to assess clearance, reassess hemodynamics every 15–30 minutes until stable.
-
Source control / definitive treatment: Treat the underlying cause — hemorrhage control, PCI, antibiotics, epinephrine, needle decompression, pericardiocentesis. Vasopressors buy time; they do not fix the problem.
-
Communication: Use SBAR communication when escalating to the physician. Clearly state the type of shock suspected, current vital signs, labs, and the intervention requested.
Medication reference: vasopressors and inotropes in shock
| Medication | Receptor activity | Typical dose range | Primary effect | Shock indication | Key nursing considerations |
|---|---|---|---|---|---|
| Norepinephrine (Levophed) | α1 >> β1 | 0.01–3 mcg/kg/min | Vasoconstriction (↑ SVR) + mild inotropy | First-line: septic, distributive; cardiogenic (second-line) | Central line required; monitor for peripheral vasoconstriction, limb ischemia; do not abruptly discontinue |
| Epinephrine | α1, β1, β2 | 0.01–0.5 mcg/kg/min | Vasoconstriction + strong inotropy + bronchodilation | Anaphylactic shock (IM first-line 0.3–0.5 mg); vasopressor-refractory shock | IM route for anaphylaxis (anterolateral thigh); IV infusion requires central access; monitor for hyperglycemia, tachyarrhythmia |
| Dopamine | Dose-dependent: D1, β1, α1 | 2–20 mcg/kg/min | Low dose: splanchnic vasodilation; mid: inotropy; high: vasoconstriction | Historically: bradycardic cardiogenic shock; largely replaced by norepinephrine + dobutamine | Higher rate of arrhythmias than norepinephrine (SOAP II trial); central line preferred; monitor for tachyarrhythmias |
| Dobutamine | β1 > β2 | 2–20 mcg/kg/min | Positive inotropy → ↑ CO; mild vasodilation (↓ SVR) | Cardiogenic shock (↑ contractility); adjunct in septic shock with low CO | May worsen hypotension (vasodilatory effect); combine with norepinephrine; monitor for tachycardia and arrhythmias; do not use in hypovolemic shock |
| Vasopressin (Pitressin) | V1 (vascular) | 0.03–0.04 units/min (fixed dose) | Vasoconstriction via vascular smooth muscle V1 receptors (norepinephrine-sparing) | Adjunct in septic shock (add when norepinephrine dose escalating); neurogenic shock | Not titrated by hemodynamic response — fixed-dose adjunct; monitor for mesenteric/digital ischemia; central line required |
| Phenylephrine | Pure α1 | 0.5–6 mcg/kg/min | Pure vasoconstriction (↑ SVR), no inotropy | Neurogenic shock; distributive shock when tachyarrhythmia limits norepinephrine use | Can cause reflex bradycardia; avoid in cardiogenic shock (pure afterload increase worsens pump failure); may be given peripherally short-term |
All vasoactive infusions require continuous hemodynamic monitoring. Titrate to MAP ≥65 mmHg (or physician-specified target). Wean gradually — abrupt discontinuation can precipitate hemodynamic collapse. Review the cardiovascular medications nursing guide and ICU critical care reference for broader vasopressor context.
Common NCLEX pitfalls around shock
1. Confusing cardiogenic shock positioning with other shock types. Elevating the legs is appropriate for hypovolemic and distributive shock (increases venous return). In cardiogenic shock, this worsens pulmonary edema. HOB at 30–45° is correct for cardiogenic shock. Position the patient based on the shock mechanism, not a single memorized rule.
2. Assuming tachycardia always accompanies shock. Neurogenic shock presents with bradycardia because sympathetic outflow is interrupted. A patient with spinal cord injury, hypotension, and bradycardia — not tachycardia — points directly to neurogenic shock.
3. Mistaking early distributive shock for a stable patient. Warm, flushed skin and a bounding pulse in distributive shock can look deceptively benign. Tachycardia and hypotension are present, but the patient may appear less distressed than in hypovolemic shock. Lactate and urine output are the key indicators — an elevated lactate ≥2 mmol/L signals tissue hypoperfusion regardless of skin temperature.
4. Giving fluids in cardiogenic shock. Aggressive fluid resuscitation worsens cardiogenic shock. PCWP is already elevated (full tank); more volume increases pulmonary edema. The intervention is inotropic support and potential diuresis after hemodynamic stabilization.
5. Delaying epinephrine in anaphylaxis. Antihistamines (diphenhydramine) and corticosteroids are adjuncts in anaphylaxis — they do not reverse bronchospasm or shock. Epinephrine IM is the first-line, life-saving intervention. On NCLEX, epinephrine always comes first.
6. Missing obstructive shock features. JVD + hypotension + absent breath sounds = tension pneumothorax until proven otherwise. JVD + hypotension + muffled heart sounds = cardiac tamponade. These presentations require immediate procedural intervention, not vasopressors or fluids as primary treatment. See the trauma and emergency nursing reference for primary survey priorities.
7. Forgetting lactate clearance as an endpoint. Volume resuscitation targets in septic shock are guided by lactate clearance (≥10% reduction per 2 hours) and MAP, not solely by fluid volumes given. A patient who receives 30 mL/kg crystalloid but whose lactate has not cleared still needs reassessment and potential vasopressor escalation.
Related resources
- Sepsis nursing guide — Surviving Sepsis Campaign bundle, early goal-directed care
- Septic shock nursing guide — dedicated septic shock protocols
- ICU critical care nursing reference — hemodynamic monitoring, ventilator management, ABCDEF bundle
- Trauma and emergency nursing reference — primary survey, triage, emergency medications
- DIC nursing reference — coagulopathy in shock states
- Anemia nursing reference — hemorrhage and red cell considerations
- DVT/PE nursing guide — pulmonary embolism assessment and anticoagulation
- ABG interpretation guide — respiratory and metabolic acid-base in shock
- Electrolyte imbalances reference — hypokalemia, lactic acidosis, and shock-related electrolyte disturbances
- Cardiovascular medications nursing guide — vasopressor and inotrope pharmacology
- Spinal cord injury nursing guide — neurogenic shock context
- Patient positioning guide — position selection by condition